One Endo

Every year, millions of Americans experience dental pain severe enough to require endodontic intervention, yet access to specialist-level root canal care remains fragmented, inconsistent, and often delivered through large corporate dental chains that prioritize volume over clinical excellence. The patient who walks into an endodontic office is typically anxious, in pain, and desperate for a skilled clinician in a clean, technologically advanced environment — not a revolving door of associate dentists working under private equity pressure. One Endo franchise was built specifically to solve this problem. Founded in 2022 by Dr. Dean Saccomanno and Dr. Nick Mastroianni, two highly experienced endodontists who launched their first practices in New York and Connecticut, One Endo was designed from the ground up as a doctor-owned, clinician-led alternative to the corporate dental model. The company officially launched its franchising program in 2023, headquartered in Mamaroneck, New York, and has grown to nine operating practices in its first three years — with 11 total locations anticipated by 2025. What makes the One Endo franchise opportunity structurally different from virtually every other dental franchise on the market is its explicit rejection of both the Dental Support Organization model and private equity partnership, a design choice that allows doctor-franchisees to retain 100% ownership of their individual practices. The brand spans geographies from New York and Connecticut to Los Angeles, with a Miami practice slated for summer launch, signaling deliberate national expansion. For franchise investors who are licensed endodontists seeking to build equity in a private practice without surrendering clinical autonomy to a DSO or corporate group, One Endo represents a franchise opportunity at the intersection of healthcare specialization, entrepreneurial ownership, and a rapidly expanding specialty dental market.

The global endodontics market was valued at approximately USD 2.49 billion in 2025, and multiple independent market research analyses project sustained growth through the next decade. One forecast places the market expanding from USD 2.58 billion in 2026 to USD 3.38 billion by 2034, representing a compound annual growth rate of 3.44%. A parallel analysis estimates the market at USD 2.16 billion in 2026 growing to USD 2.83 billion by 2031 at a CAGR of 5.55%, while the global endodontic devices market specifically was estimated at USD 1.75 billion in 2024 and projected to reach USD 2.35 billion by 2030 at a 5.0% CAGR. North America dominates this specialty, commanding approximately 41% of global endodontics market share in 2025. The demand drivers are structural and demographic, not cyclical. The U.S. population is aging, and older patients are retaining their natural teeth at higher rates than previous generations, generating sustained demand for pulp preservation and root canal therapy. A June 2024 CDC report confirmed that one in four American adults between the ages of 20 and 64 has at least one untreated cavity, representing a direct pipeline to endodontic referral. Simultaneously, rising patient awareness around tooth preservation versus extraction is shifting clinical decision-making toward endodontic intervention. On the technology side, the widespread adoption of CBCT 3D scanners, surgical operating microscopes, rotary instrumentation systems, AI-guided diagnostics, and biocompatible filling materials is elevating both treatment outcomes and patient willingness to accept specialty procedures. The endodontics market is meaningfully fragmented, with independent solo practitioners, group DSO platforms, and emerging franchise models all competing for specialist referrals from general dentists. This fragmentation creates genuine white space for a branded, systems-driven franchise model that can offer referring dentists a consistent, high-quality specialist partner across multiple markets.

The One Endo franchise investment requires serious capitalization, befitting the clinical infrastructure and specialized equipment a premium endodontic practice demands. The initial franchise fee is $75,000, a figure that reflects access to a proprietary brand system, established operational frameworks, marketing infrastructure, and an active referral network — not simply a license to use a name. Total initial investment ranges from $886,000 on the low end to $1,559,000 on the high end, a spread driven by geography, real estate selection, practice size, and the significant cost of specialized endodontic equipment. Within that range, leasehold improvements alone account for $200,000 to $300,000 of the budget, while rent and security deposits for the first three months are estimated at $10,000 to $20,625. Site selection assistance is available at a cost of $0 to $1,500, reflecting the franchisor's role in helping secure competitive real estate positions. The ongoing fee structure consists of a fixed monthly royalty of $6,000 — notably a flat fee rather than a percentage of revenue, which carries meaningful implications for high-producing practices — plus a $2,000 per month marketing and administrative support fee, bringing total ongoing fixed obligations to $8,000 per month or $96,000 annually before any variable operating costs. Prospective One Endo franchisees must demonstrate a minimum net worth of $1,000,000 and hold at least $250,000 in liquid capital to qualify, placing this squarely in the premium franchise investment category. For context, the total investment range of $886,000 to $1,559,000 is consistent with other healthcare specialty franchise concepts that require custom buildouts, medical-grade equipment, and compliance-driven facility design. One Endo has developed banking partnerships to assist franchisees in navigating the financing transition to practice ownership, and while SBA eligibility specifics require direct lender consultation, healthcare franchise concepts with strong brand systems and identifiable equipment assets have historically performed well in SBA lending reviews. The fixed royalty structure, as opposed to a percentage-based royalty, means that a practice producing $1.5 million annually faces a materially different royalty burden than one producing $800,000 — a factor sophisticated investors should model carefully before signing.

The One Endo operating model is built around a single, focused clinical service line: advanced root canal treatment and endodontic microsurgery. Unlike multi-specialty dental franchises that require generalist management of diverse service offerings, One Endo franchisees operate within a defined specialty scope, which simplifies hiring, training, equipment procurement, and clinical workflow design. The doctor-owner is the clinical anchor of each practice, supported by a team of clinical assistants and front office staff whose size scales with procedure volume. One Endo explicitly positions its model as owner-operated rather than absentee-managed — the franchisee is expected to be a licensed, practicing endodontist who personally delivers or directly supervises the clinical product. The franchisor provides a comprehensive support infrastructure encompassing site selection guidance, lease and purchase negotiation assistance, digital marketing strategy targeting both referring general dentists and direct patient acquisition, business development resources, and access to a curated network of banking and technology partners. Training and onboarding are designed to prepare doctor-owners not just clinically — which One Endo assumes they already possess — but operationally and entrepreneurially, equipping them with systems for scheduling, patient management, referral development, and financial tracking. The franchise model supports a scalable multi-practice ownership structure, meaning a successful single-unit operator can expand to own two or more locations under the same brand umbrella, amplifying both revenue potential and brand presence within a market. Territory structure and exclusivity terms are negotiated through the franchise development process, with One Endo's active expansion into major metros including New York, Connecticut, Los Angeles, and Miami suggesting a deliberate strategy of planting flagship practices in high-density, high-referral markets before penetrating secondary cities.

Item 19 financial performance data is not disclosed in the current Franchise Disclosure Document. This is not uncommon among emerging franchise brands in their early growth phases, particularly those that launched franchising as recently as 2023 and have fewer than a dozen operating units producing sufficiently mature financial data to make statistically meaningful representations. What is available, however, are industry-level benchmarks that frame the revenue opportunity with reasonable precision. The endodontics specialty is a high-ticket, low-volume procedure category: average root canal fees in the United States range from approximately $700 to $1,500 per procedure depending on tooth type and geography, with endodontic microsurgery commands premium pricing above that range. A practice performing 10 to 15 root canal procedures per day at average fees of $1,000 to $1,200 per case would generate gross revenues in the range of $1.0 million to $2.2 million annually, depending on practice days and case mix. Established solo endodontic practices in major U.S. metropolitan markets routinely achieve annual collections of $1.2 million to $2.0 million, with top-tier practices in high-density urban markets exceeding $2.5 million. Against the fixed royalty structure of $72,000 annually ($6,000 per month) plus $24,000 in marketing and administrative fees, a practice producing $1.5 million in gross revenue carries a combined franchisor fee burden of approximately 6.4% — competitive with percentage-based royalties common across healthcare franchise categories. The total investment ceiling of $1,559,000 against projected annual revenues of $1.2 million to $2.0 million for a mature practice implies a payback period of roughly two to five years at the practice level, before accounting for debt service on financed construction and equipment. Investors should request detailed unit-level financial data during the discovery process and consult directly with operating One Endo franchisees as part of franchise validation to build their own revenue models with current, practice-specific data.

One Endo's growth trajectory reflects a disciplined, quality-over-quantity expansion philosophy. Nine practices launched in the first three years since founding in 2022, with the total projected to reach 11 locations by 2025 — a controlled expansion pace that prioritizes franchisee success and brand consistency over rapid unit proliferation. The company's geographic footprint already spans both coasts, with established presences in New York and Connecticut where the founders originally built their practices, a location in Los Angeles representing the brand's entry into the massive Southern California market, and a Miami launch planned for summer 2025 that would give One Endo its first presence in one of the fastest-growing major metros in the United States. The founders have described the current expansion phase as an "inaugural World Tour" to identify Endo Entrepreneurs, a positioning that communicates both ambition and selectivity. The competitive moat One Endo is constructing rests on several structural advantages: the founders' credibility as practicing endodontists rather than corporate operators, the brand's explicit opposition to DSO and private equity models which resonates deeply with clinician-entrepreneurs who have watched corporate consolidation erode doctor autonomy across dentistry, proprietary systems built specifically for endodontic practice management rather than adapted from generalist dental models, and a growing network of doctor-owners who collectively benefit from shared marketing resources, technology partnerships, and brand recognition that an individual solo practitioner cannot access. The broader entrepreneurship culture driving interest in franchise ownership across healthcare specialties is a measurable macro tailwind, as the American dental market has seen significant DSO consolidation over the past decade, creating a growing cohort of endodontists who want the resources of a network without surrendering their equity or their clinical voice.

The ideal One Endo franchisee is a licensed endodontist with demonstrated clinical competency in root canal therapy and endodontic microsurgery who also possesses entrepreneurial motivation and the financial capacity to meet the $1,000,000 minimum net worth and $250,000 liquid capital requirements. This is not a franchise model for career changers, passive investors, or semi-retired practitioners looking for a low-touch income stream — the owner-operator model demands active clinical participation and practice leadership. Candidates who have trained in endodontic residency programs, accumulated several years of associate or practice experience, and grown frustrated by the limitations of DSO employment or traditional group practice compensation structures represent the brand's primary recruitment target. The scalable multi-practice architecture means that ambitions extend operators can reasonably plan a path from one to three locations over a five-to-seven year horizon, particularly in markets where general dentist referral networks are deep and population demographics are favorable. Available territories are concentrated in major U.S. metropolitan areas, with current evidence of expansion activity in New York, Connecticut, California, and Florida. The franchise agreement framework, site selection support, and banking partnerships are specifically engineered to compress the timeline from franchise signing to practice opening, a critical factor given the significant capital committed at outset. Prospective franchisees should engage in thorough validation conversations with existing One Endo doctor-owners about the referral ramp timeline, the actual time from lease signing to first patient, and the realistic revenue trajectory in year one versus year three.

The investment thesis for the One Endo franchise opportunity synthesizes several compelling elements: a growing specialty dental market valued at over $2.49 billion globally in 2025 with a projected CAGR of up to 5.55% through 2031, a structural demographic tailwind from an aging population retaining natural teeth at unprecedented rates, a differentiated brand positioning that explicitly rejects DSO and private equity structures to appeal to the most entrepreneurially motivated segment of the endodontic specialist workforce, a fixed-fee royalty model that rewards high-producing practices disproportionately compared to percentage-based alternatives, and a founding team of actively practicing endodontists whose clinical credibility anchors the brand's value proposition to both franchisees and the referring dentist community. The brand's controlled growth from founding in 2022 to nine operating practices by 2025 suggests a franchisor focused on building durable unit economics rather than collecting franchise fees from underprepared operators. The absence of Item 19 disclosure reflects the brand's early-stage franchise lifecycle rather than a structural weakness, and investors who conduct thorough validation with existing franchisees can build revenue models grounded in actual practice data rather than franchisor projections. The total investment range of $886,000 to $1,559,000 is substantial, but it is commensurate with the clinical infrastructure required to deliver premium endodontic care in competitive urban markets, and the $1,000,000 minimum net worth requirement ensures that franchisees enter with sufficient financial resilience to navigate the practice ramp period. PeerSense provides exclusive due diligence data including SBA lending history, FPI score, location maps with Google ratings, FDD financial data, and side-by-side comparison tools to help franchise investors evaluate One Endo against every alternative in the specialty dental and healthcare franchise categories. Explore the complete One Endo franchise profile on PeerSense to access the full suite of independent franchise intelligence data.